Editas Medicine
(EDIT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 203,519 | 259,884 | 337,834 | 354,918 | 139,682 |
| Marketable Securities | 296,326 | 297,957 | 272,719 | 270,415 | 262,428 |
| Receivables | 267 | 251 | 331 | 672 | 6,048 |
| TOTAL | $507,310 | $567,608 | $616,292 | $632,316 | $419,087 |
| Non-Current Assets | |||||
| PPE Net | 17,118 | 15,631 | 14,910 | 14,095 | 14,020 |
| Investments And Advances | 120,071 | 99,198 | 87,584 | 97,890 | 109,664 |
| Other Non-Current Assets | 32,984 | 34,582 | 37,094 | 35,993 | 29,831 |
| TOTAL | $170,173 | $149,411 | $139,588 | $147,978 | $153,515 |
| Total Assets | $677,483 | $717,019 | $755,880 | $780,294 | $572,602 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,050 | 3,402 | 4,415 | 8,910 | 6,408 |
| Accrued Expenses | 20,192 | 14,575 | 18,627 | 15,132 | 24,046 |
| TOTAL | $46,884 | $50,907 | $66,016 | $64,010 | $58,208 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 11,333 | 22,667 | 34,000 | 32,704 | 20,943 |
| Other Non-Current Liabilities | 16,069 | 18,430 | 21,282 | 21,621 | 46,824 |
| TOTAL | $76,957 | $79,318 | $76,503 | $78,288 | $120,808 |
| Total Liabilities | $123,841 | $130,225 | $142,519 | $142,298 | $179,016 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,519 | 68,399 | 68,261 | 67,826 | 67,363 |
| Common Shares | 7 | 7 | 7 | 7 | 6 |
| Retained earnings | -857,699 | -816,263 | -777,181 | -721,925 | -665,197 |
| Other shareholders' equity | -493 | -64 | -71 | -73 | -46 |
| TOTAL | $553,642 | $586,794 | $613,361 | $637,996 | $393,586 |
| Total Liabilities And Equity | $677,483 | $717,019 | $755,880 | $780,294 | $572,602 |